Related Articles
Anti‑4‑1BB antibody‑based combination therapy augments antitumor immunity by enhancing CD11c+CD8+ T cells in renal cell carcinoma
Uncommon gastrointestinal bleeding during targeted therapy for advanced renal cell carcinoma: A report of four cases
Establishment and characterization of a highly immunogenic human renal carcinoma cell line
Synergistic effects of low‑dose chemotherapy and T cells in renal cell carcinoma
Potential biomarkers for the therapeutic efficacy of sorafenib, sunitinib and everolimus